Stocktoria
PUMA BIOTECHNOLOGY, INC. PBYI
Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2012-03-21
PUMA BIOTECHNOLOGY, INC. institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | 1,942,413 | $12.4M | 3.83% |
| BlackRock Finance, Inc. | 3,572,806 | $11.6M | 7.05% |
| MILLENNIUM MANAGEMENT LLC | 1,477,519 | $9.4M | 2.92% |
| AQR CAPITAL MANAGEMENT LLC | 800,194 | $5.1M | 1.58% |
| D. E. Shaw & Co., Inc. | 351,235 | $2.2M | 0.69% |
| CITADEL ADVISORS LLC | 29,959 | $191,438 | 0.06% |
| TWO SIGMA INVESTMENTS, LP | 13,000 | $83,070 | 0.03% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.